Skip to main content
Top
Published in: Cost Effectiveness and Resource Allocation 1/2003

Open Access 01-12-2003 | Methodology

Programme costs in the economic evaluation of health interventions

Published in: Cost Effectiveness and Resource Allocation | Issue 1/2003

Login to get access

Abstract

Estimating the costs of health interventions is important to policy-makers for a number of reasons including the fact that the results can be used as a component in the assessment and improvement of their health system performance. Costs can, for example, be used to assess if scarce resources are being used efficiently or whether there is scope to reallocate them in a way that would lead to improvements in population health. As part of its WHO-CHOICE project, WHO has been developing a database on the overall costs of health interventions in different parts of the world as an input to discussions about priority setting.
Programme costs, defined as costs incurred at the administrative levels outside the point of delivery of health care to beneficiaries, may comprise an important component of total costs. Cost-effectiveness analysis has sometimes omitted them if the main focus has been on personal curative interventions or on the costs of making small changes within the existing administrative set-up. However, this is not appropriate for non-personal interventions where programme costs are likely to comprise a substantial proportion of total costs, or for sectoral analysis where questions of how best to reallocate all existing health resources, including administrative resources, are being considered.
This paper presents a first effort to systematically estimate programme costs for many health interventions in different regions of the world. The approach includes the quantification of resource inputs, choice of resource prices, and accounts for different levels of population coverage. By using an ingredients approach, and making tools available on the World Wide Web, analysts can adapt the programme costs reported here to their local settings. We report results for a selected number of health interventions and show that programme costs vary considerably across interventions and across regions, and that they can contribute substantially to the overall costs of interventions.
Literature
1.
go back to reference Hutubessy RCW, Baltussen RMPM, Tan Torres-Edejer T, Evans DB: Generalised cost-effectiveness analysis: an aid to decision making in health. Applied Health Economics and Health Policy 2002, 1: 89–95.PubMed Hutubessy RCW, Baltussen RMPM, Tan Torres-Edejer T, Evans DB: Generalised cost-effectiveness analysis: an aid to decision making in health. Applied Health Economics and Health Policy 2002, 1: 89–95.PubMed
2.
go back to reference Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349: 1436–1442. 10.1016/S0140-6736(96)07495-8PubMedCrossRef Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 1997, 349: 1436–1442. 10.1016/S0140-6736(96)07495-8PubMedCrossRef
3.
go back to reference Baltussen RM, Adam T, Tan Torres T, Hutubessy RC, Acharya A, Evans DB: Generalized Cost-Effectiveness Analysis: A Guide. Geneva, World Health Organization, Global Programme on Evidence for Health Policy 2002. Baltussen RM, Adam T, Tan Torres T, Hutubessy RC, Acharya A, Evans DB: Generalized Cost-Effectiveness Analysis: A Guide. Geneva, World Health Organization, Global Programme on Evidence for Health Policy 2002.
4.
go back to reference de Jonghe E, Murray CJ, Chum HJ, Nyangulu DS, Salomao A, Styblo K: Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Int J Health Plann Manage 1994, 9: 151–181.PubMedCrossRef de Jonghe E, Murray CJ, Chum HJ, Nyangulu DS, Salomao A, Styblo K: Cost-effectiveness of chemotherapy for sputum smear-positive pulmonary tuberculosis in Malawi, Mozambique and Tanzania. Int J Health Plann Manage 1994, 9: 151–181.PubMedCrossRef
5.
go back to reference Adam T, Evans DB, Koopmanschap MA: Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care, in press. Adam T, Evans DB, Koopmanschap MA: Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care, in press.
6.
go back to reference Floyd K, Wilkinson D, Gilks C: Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997, 315: 1407–1411.PubMedCentralPubMedCrossRef Floyd K, Wilkinson D, Gilks C: Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997, 315: 1407–1411.PubMedCentralPubMedCrossRef
7.
go back to reference Creese A, Parker D: Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva, World Health Organization 1994. Creese A, Parker D: Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva, World Health Organization 1994.
8.
go back to reference Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes 2 ed. Oxford, Oxford Univeristy Press 1997. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes 2 ed. Oxford, Oxford Univeristy Press 1997.
9.
go back to reference Gold MR, Siegel JE, Russel LB, Weinstein MC: Cost-effectiveness in Health and Medicine. New York, Oxford University Press 1996. Gold MR, Siegel JE, Russel LB, Weinstein MC: Cost-effectiveness in Health and Medicine. New York, Oxford University Press 1996.
10.
go back to reference Murray CJ, Evans DB, Acharya A, Baltussen RM: Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 2000, 9: 235–251. 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-OPubMedCrossRef Murray CJ, Evans DB, Acharya A, Baltussen RM: Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 2000, 9: 235–251. 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-OPubMedCrossRef
11.
go back to reference Little IMD, Mirrlees JA: Project Appraisal and Planning for Developing Countries. London, Heinemann Educational Books 1974. Little IMD, Mirrlees JA: Project Appraisal and Planning for Developing Countries. London, Heinemann Educational Books 1974.
12.
go back to reference Mishan EJ: Cost-benefit Analysis. London, George Allen & Unwin (Publishers) Ltd 3 Edition 1982. Mishan EJ: Cost-benefit Analysis. London, George Allen & Unwin (Publishers) Ltd 3 Edition 1982.
13.
go back to reference Creese A, Parker D: Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva, World Health Organization 1994. Creese A, Parker D: Cost Analysis in Primary Health Care: A Training Manual for Programme Managers. Geneva, World Health Organization 1994.
14.
go back to reference Walker D: How to do (or not to do)... Cost and cost-effectiveness guidelines: which ones to use? Health Policy Plan 2001, 16: 113–121. 10.1093/heapol/16.1.113PubMedCrossRef Walker D: How to do (or not to do)... Cost and cost-effectiveness guidelines: which ones to use? Health Policy Plan 2001, 16: 113–121. 10.1093/heapol/16.1.113PubMedCrossRef
15.
go back to reference World Bank: World Development Indicators 2001. Washington, D.C: World Bank 2001. World Bank: World Development Indicators 2001. Washington, D.C: World Bank 2001.
16.
go back to reference Gittinger J: Economic analysis of agricultural projects. John Hopkins Press 1984. Gittinger J: Economic analysis of agricultural projects. John Hopkins Press 1984.
17.
go back to reference Berman P, Brotowasisto , Nadjib M, Sakai S, Gani A: The costs of public primary health care services in rural Indonesia. Bull World Health Organ 1989, 67: 685–694.PubMedCentralPubMed Berman P, Brotowasisto , Nadjib M, Sakai S, Gani A: The costs of public primary health care services in rural Indonesia. Bull World Health Organ 1989, 67: 685–694.PubMedCentralPubMed
18.
go back to reference Berman P: Cost efficiency in primary health care: studies of health facilities in Indonesia. Health Policy Plan 1989, 4: 316–322.CrossRef Berman P: Cost efficiency in primary health care: studies of health facilities in Indonesia. Health Policy Plan 1989, 4: 316–322.CrossRef
19.
go back to reference Over M: The effect of scale on cost projections for a primary health care program in a developing country. Soc Sci Med 1986, 22: 351–360. 10.1016/0277-9536(86)90134-6PubMedCrossRef Over M: The effect of scale on cost projections for a primary health care program in a developing country. Soc Sci Med 1986, 22: 351–360. 10.1016/0277-9536(86)90134-6PubMedCrossRef
20.
go back to reference Limao N, Venables AJ: Infrastructure, geographical disadvantage, transport costs, and trade. World Bank Economic Review 2001, 15: 451–479. 10.1093/wber/15.3.451CrossRef Limao N, Venables AJ: Infrastructure, geographical disadvantage, transport costs, and trade. World Bank Economic Review 2001, 15: 451–479. 10.1093/wber/15.3.451CrossRef
21.
go back to reference Roncek DW: Learning more from tobit coefficients: extending a comparative analysis of political protest. American Sociological Review 1992, 57: 503–507.CrossRef Roncek DW: Learning more from tobit coefficients: extending a comparative analysis of political protest. American Sociological Review 1992, 57: 503–507.CrossRef
22.
go back to reference Gusein-Zade SM: Comments on "A note on the location of medical facilities" by Z. Drezner. Journal of Regional Sciences 1992, 32: 229–231.CrossRef Gusein-Zade SM: Comments on "A note on the location of medical facilities" by Z. Drezner. Journal of Regional Sciences 1992, 32: 229–231.CrossRef
23.
go back to reference Khan MM, Ali D, Ferdousy Z, Al Mamun A: A cost-minimization approach to planning the geographical distribution of health facilities. Health Policy Plan 2001, 16: 264–272. 10.1093/heapol/16.3.264PubMedCrossRef Khan MM, Ali D, Ferdousy Z, Al Mamun A: A cost-minimization approach to planning the geographical distribution of health facilities. Health Policy Plan 2001, 16: 264–272. 10.1093/heapol/16.3.264PubMedCrossRef
24.
go back to reference Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, Grinstead O, Coates T: Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000, 356: 113–121. 10.1016/S0140-6736(00)02447-8PubMedCrossRef Sweat M, Gregorich S, Sangiwa G, Furlonge C, Balmer D, Kamenga C, Grinstead O, Coates T: Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania. Lancet 2000, 356: 113–121. 10.1016/S0140-6736(00)02447-8PubMedCrossRef
25.
go back to reference World Health Organization: The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, World Health Organization 2002. World Health Organization: The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, World Health Organization 2002.
26.
go back to reference Baltussen RM, Hutubessy RC, Evans DB, Murray CJ: Uncertainty in cost-effectiveness analysis: Probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care 2002, 18: 112–119.PubMed Baltussen RM, Hutubessy RC, Evans DB, Murray CJ: Uncertainty in cost-effectiveness analysis: Probabilistic uncertainty analysis and stochastic league tables. Int J Technol Assess Health Care 2002, 18: 112–119.PubMed
27.
go back to reference Hutubessy RC, Baltussen RM, Evans DB, Barendregt JJ, Murray CJ: Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ 2001, 10: 473–477. 10.1002/hec.614PubMedCrossRef Hutubessy RC, Baltussen RM, Evans DB, Barendregt JJ, Murray CJ: Stochastic league tables: communicating cost-effectiveness results to decision-makers. Health Econ 2001, 10: 473–477. 10.1002/hec.614PubMedCrossRef
28.
go back to reference WHO Commission on Macroeconomics and Health: Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health. Geneva, World Health Organization 2001. WHO Commission on Macroeconomics and Health: Macroeconomics and Health: Investing in Health for Economic Development. Report of the Commission on Macroeconomics and Health. Geneva, World Health Organization 2001.
Metadata
Title
Programme costs in the economic evaluation of health interventions
Publication date
01-12-2003
Published in
Cost Effectiveness and Resource Allocation / Issue 1/2003
Electronic ISSN: 1478-7547
DOI
https://doi.org/10.1186/1478-7547-1-1

Other articles of this Issue 1/2003

Cost Effectiveness and Resource Allocation 1/2003 Go to the issue